James O Armitage
CIK 1370087 · last filed 2025-06-27
James O Armitage is a corporate insider who has filed 21 SEC Form 4 insider transactions across 4 companies since 2007. The most recent filing, for CRDF, was dated Jun 27, 2025. Across all open-market trades the lifetime net is −$1.0M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $42.3K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$42.3K
4
21
-$1.03M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CRDF | Director | 27,490 | $1.54 | $42.3K | $78.5K | 9 | 2025-06-27 |
| Cardiff Oncology, Inc. (TROV) Delisted | Director | — | — | — | $0 | 1 | 2020-05-01 |
| TESARO, Inc. (TSRO) Delisted | Director | 10,000 | — | — | -$1.11M | 9 | 2019-01-22 |
| MGI PHARMA INC (MOGN) Delisted | Director | 0 | — | — | $0 | 1 | 2007-05-09 |
Recent Filings
21 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-06-27 | CRDF | Grant (A) | — | $0 | EDGAR |
| 2024-07-01 | CRDF | Grant (A) | — | $0 | EDGAR |
| 2023-06-20 | CRDF | Grant (A) | — | $0 | EDGAR |
| 2022-10-11 | CRDF | Buy (P) | +13,000 | $20.2K | EDGAR |
| 2022-03-10 | CRDF | Grant (A) | — | $0 | EDGAR |
| 2021-06-14 | CRDF | Grant (A) | — | $0 | EDGAR |
| 2021-05-27 | CRDF | Buy (P) | +4,000 | $43.3K | EDGAR |
| 2020-06-19 | CRDF | Grant (A) | — | $0 | EDGAR |
| 2020-05-18 | CRDF | Buy (P) | +10,490 | $15.0K | EDGAR |
| 2020-05-01 | Cardiff Oncology, Inc. (TROV) Delisted | Grant (A) | — | $0 | EDGAR |